Imaging and fluid biomarkers in frontotemporal dementia

[1]  H. Mitsumoto,et al.  [A prognostic biomarker in amyotrophic lateral sclerosis]. , 2018, Rinsho shinkeigaku = Clinical neurology.

[2]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[3]  William T. Hu,et al.  Poly(Gp) Proteins Are A Useful Pharmacodynamic Marker For C9Orf72-Associated Amyotrophic Lateral Sclerosis , 2017 .

[4]  K. Blennow,et al.  Blood-based NfL , 2017, Neurology.

[5]  Virginia M. Y. Lee,et al.  Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies , 2017, Brain : a journal of neurology.

[6]  De La Sayette,et al.  Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET , 2017, Brain Imaging and Behavior.

[7]  D. Lulé,et al.  Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[8]  Keith A. Johnson,et al.  Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies , 2017, Annals of neurology.

[9]  C. Rowe,et al.  Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy , 2017, European journal of neurology.

[10]  D. Kasselimis,et al.  Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia. , 2016, Journal of Alzheimer's disease : JAD.

[11]  Rebecca M. E. Steketee,et al.  Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI , 2016, European Radiology.

[12]  A. Takeda,et al.  In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET , 2016, Neurology.

[13]  O. Hansson,et al.  Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy , 2016, Acta Neuropathologica.

[14]  Y. Pijnenburg,et al.  Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study. , 2016, Journal of Alzheimer's Disease.

[15]  E. Westman,et al.  Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors. , 2016, Journal of Alzheimer's disease : JAD.

[16]  M. Jorge Cardoso,et al.  Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia , 2016, Neurology.

[17]  D. Perani,et al.  The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia , 2016, Journal of Alzheimer's disease : JAD.

[18]  E. Hornstein,et al.  Vulnerability of microRNA biogenesis in FTD–ALS , 2016, Brain Research.

[19]  G. Jicha,et al.  Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  N. Schuff,et al.  Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD , 2016, Annals of clinical and translational neurology.

[21]  Nick C Fox,et al.  Advances in neuroimaging in frontotemporal dementia , 2016, Journal of neurochemistry.

[22]  Y. Pijnenburg,et al.  Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers , 2016, Dementia and Geriatric Cognitive Disorders Extra.

[23]  M. Staufenbiel,et al.  Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases , 2016, Neuron.

[24]  S. Ourselin,et al.  Neurofilament light chain: a biomarker for genetic frontotemporal dementia , 2016, Annals of clinical and translational neurology.

[25]  O. Hansson,et al.  18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers , 2016, Brain : a journal of neurology.

[26]  K. Blennow,et al.  CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis , 2016, The Lancet Neurology.

[27]  M. Synofzik,et al.  Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  Michelle K. Cahill,et al.  Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation , 2016, Cell.

[29]  C. Heyser,et al.  Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs , 2016, Neuron.

[30]  J. Rowe,et al.  Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes , 2016, Neurology.

[31]  Olivier Piguet,et al.  On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. , 2016, Brain : a journal of neurology.

[32]  R. Rademakers,et al.  Genetics of FTLD: overview and what else we can expect from genetic studies , 2016, Journal of neurochemistry.

[33]  A. Picco,et al.  Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  Junming Shao,et al.  Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study , 2016, The Journal of Nuclear Medicine.

[35]  Nick C Fox,et al.  MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases , 2016, Brain : a journal of neurology.

[36]  A. Boxer,et al.  Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD , 2016, Journal of Neural Transmission.

[37]  K. Blennow,et al.  Plasma neurofilament light chain predicts progression in progressive supranuclear palsy , 2016, Annals of clinical and translational neurology.

[38]  S. Rombouts,et al.  Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study☆ , 2016, NeuroImage: Clinical.

[39]  Y. Pijnenburg,et al.  Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics , 2016, Alzheimer's & dementia.

[40]  N. Tomita,et al.  Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration , 2016, Journal of neurochemistry.

[41]  K. Blennow,et al.  CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease , 2016, Annals of clinical and translational neurology.

[42]  S. Mead,et al.  Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations , 2015, Neuropathology and applied neurobiology.

[43]  W. M. van der Flier,et al.  Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes , 2015, Alzheimer's & dementia.

[44]  K. Blennow,et al.  Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease , 2015, Annals of clinical and translational neurology.

[45]  J. Hodges,et al.  Divergent Longitudinal Propagation of White Matter Degradation in Logopenic and Semantic Variants of Primary Progressive Aphasia. , 2015, Journal of Alzheimer's disease : JAD.

[46]  D. Galimberti,et al.  Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers , 2015, Brain, Behavior, and Immunity.

[47]  K. Blennow,et al.  Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[48]  Jeroen van der Grond,et al.  Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease , 2015, Front. Hum. Neurosci..

[49]  L. Wilkins.  Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis , 2015, Neurology.

[50]  Stanley Durrleman,et al.  Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? , 2015, Journal of Alzheimer's disease : JAD.

[51]  M. Filippi,et al.  MRI signatures of the frontotemporal lobar degeneration continuum , 2015, Human brain mapping.

[52]  P. Steinacker,et al.  Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives. , 2015, Biochimica et biophysica acta.

[53]  N. Pearce,et al.  Neurofilament light chain , 2015, Neurology.

[54]  Marion Smits,et al.  Early-stage differentiation between presenile Alzheimer’s disease and frontotemporal dementia using arterial spin labeling MRI , 2015, European Radiology.

[55]  C. Jack,et al.  Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images , 2015, European journal of neurology.

[56]  Mike P. Wattjes,et al.  Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin? , 2015, European Radiology.

[57]  M. Fernández-Matarrubia,et al.  Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes , 2015, Journal of Neurology.

[58]  J. Trojanowski,et al.  TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies , 2015, Acta neuropathologica communications.

[59]  S. Sorbi,et al.  Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[60]  P. Hartikainen,et al.  Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis with the C9ORF72 Repeat Expansion , 2015, Dementia and Geriatric Cognitive Disorders.

[61]  Veeranna,et al.  Neurofilament Subunits are Integral Components of Synapses and Modulate Neurotransmission and Behavior In Vivo , 2015, Molecular Psychiatry.

[62]  Robert I. Reid,et al.  Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia , 2015, Brain and Language.

[63]  Veronica Redaelli,et al.  Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis , 2015, The Lancet Neurology.

[64]  D. Neary,et al.  Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration , 2015, Neurobiology of Aging.

[65]  Christopher C Rowe,et al.  Tau imaging: early progress and future directions , 2015, The Lancet Neurology.

[66]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[67]  G. Magnani,et al.  Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia. , 2014, Journal of Alzheimer's disease : JAD.

[68]  Karmen K. Yoder,et al.  Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers. , 2014, American journal of neurodegenerative disease.

[69]  K. Blennow,et al.  CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival , 2014, Neurology.

[70]  Nick C Fox,et al.  Longitudinal Diffusion Tensor Imaging in Frontotemporal Dementia , 2014, Annals of neurology.

[71]  Giovanni Coppola,et al.  Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. , 2014, Brain : a journal of neurology.

[72]  K. Ishii.  PET Approaches for Diagnosis of Dementia , 2014, American Journal of Neuroradiology.

[73]  M. Filippi,et al.  Disrupted brain connectome in semantic variant of primary progressive aphasia , 2014, Neurobiology of Aging.

[74]  Franco Cauda,et al.  Multimodal fMRI Resting-State Functional Connectivity in Granulin Mutations: The Case of Fronto-Parietal Dementia , 2014, PloS one.

[75]  Peter K. Todd,et al.  Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS , 2014, Neuron.

[76]  L. Ungar,et al.  The power of neuroimaging biomarkers for screening frontotemporal dementia , 2014, Human brain mapping.

[77]  A. Drzezga,et al.  Imaging Frontotemporal Lobar Degeneration , 2014, Current Neurology and Neuroscience Reports.

[78]  S. Lui,et al.  Anatomical deficits in adult posttraumatic stress disorder: A meta-analysis of voxel-based morphometry studies , 2014, Behavioural Brain Research.

[79]  A. Laird,et al.  Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses – The case of behavioral variant frontotemporal dementia , 2014, Cortex.

[80]  Patrizia Rizzu,et al.  Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia , 2013, Neurology.

[81]  Mike P. Wattjes,et al.  Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies , 2014, European Radiology.

[82]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[83]  J. Hodges,et al.  Longitudinal white matter changes in frontotemporal dementia subtypes , 2014, Human brain mapping.

[84]  S. Engelborghs,et al.  TDP-43 AS A BIOMARKER FOR FRONTOTEMPORAL LOBE DEGENERATION: A SYSTEMATIC REVIEW OF EXISTING ANTIBODIES , 2014, Alzheimer's & Dementia.

[85]  Michael T. Heneka,et al.  Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.

[86]  J. Hodges,et al.  Phonologic errors as a clinical marker of the logopenic variant of PPA , 2014, Neurology.

[87]  C. Nilsson,et al.  Age-Related Incidence and Family History in Frontotemporal Dementia: Data from the Swedish Dementia Registry , 2014, PloS one.

[88]  Cindee M. Madison,et al.  Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology , 2014, NeuroImage: Clinical.

[89]  Nick C Fox,et al.  Profiles of white matter tract pathology in frontotemporal dementia , 2014, Human brain mapping.

[90]  A. Chiò,et al.  The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[91]  L. Grinberg,et al.  Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration , 2014, Annals of neurology.

[92]  J. Molinuevo,et al.  Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[93]  Chadwick M. Hales,et al.  Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP , 2013, Neurology.

[94]  V. Sossi,et al.  Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers , 2013, Neurology.

[95]  Didier Dormont,et al.  Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. , 2013, Brain : a journal of neurology.

[96]  Massimo Filippi,et al.  Functional network connectivity in the behavioral variant of frontotemporal dementia , 2013, Cortex.

[97]  B. Miller,et al.  Anterior temporal lobe degeneration produces widespread network-driven dysfunction. , 2013, Brain : a journal of neurology.

[98]  Sandra E Black,et al.  Salience network resting-state activity: prediction of frontotemporal dementia progression. , 2013, JAMA neurology.

[99]  Bryan J. Traynor,et al.  GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia , 2013, Front. Hum. Neurosci..

[100]  Cheryl L. Grady,et al.  Abnormal network connectivity in frontotemporal dementia: Evidence for prefrontal isolation , 2013, Cortex.

[101]  Nick C Fox,et al.  White matter tract signatures of the progressive aphasias , 2013, Neurobiology of Aging.

[102]  C. Nilsson,et al.  Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia , 2013, BMC Neurology.

[103]  H. Rosen,et al.  Neuroimaging in frontotemporal dementia , 2013, International review of psychiatry.

[104]  Elizabeth Rochon,et al.  Whole‐brain white matter disruption in semantic and nonfluent variants of primary progressive aphasia , 2013, Human brain mapping.

[105]  E. Kremmer,et al.  The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.

[106]  B. Avants,et al.  White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[107]  N. Schuff,et al.  MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. , 2012, Journal of Alzheimer's disease : JAD.

[108]  C. Caltagirone,et al.  Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD , 2012, Neurobiology of Aging.

[109]  D. Geschwind,et al.  Frontotemporal dementia due to C9ORF72 mutations , 2012, Neurology.

[110]  J. Gee,et al.  White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration , 2012, Neurology.

[111]  Q. Gong,et al.  Gray Matter Atrophy in Behavioral Variant Frontotemporal Dementia: A Meta-Analysis of Voxel-Based Morphometry Studies , 2012, Dementia and Geriatric Cognitive Disorders.

[112]  Murray Grossman,et al.  CSF biomarkers cutoffs: the importance of coincident neuropathological diseases , 2012, Acta Neuropathologica.

[113]  C. Jack,et al.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics , 2012, Brain : a journal of neurology.

[114]  J. Whitwell,et al.  Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology , 2012, Nature Reviews Neurology.

[115]  L. Agnati,et al.  Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study , 2011, Neurodegenerative Diseases.

[116]  G. Frisoni,et al.  Functional network disruption in the degenerative dementias , 2011, The Lancet Neurology.

[117]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[118]  David T. Jones,et al.  Altered functional connectivity in asymptomatic MAPT subjects , 2011, Neurology.

[119]  D. Galimberti,et al.  Faculty Opinions recommendation of Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. , 2011 .

[120]  M Filippi,et al.  Whole brain structural changes predict the mild cognitive impairment to Alzheimer's disease conversion: Evidence from the Alzheimer's Disease Neuroimaging Initiative , 2011, Alzheimer's & Dementia.

[121]  S. Cappa,et al.  White matter damage in frontotemporal lobar degeneration spectrum , 2011, Alzheimer's & Dementia.

[122]  J. Hodges,et al.  Neuropathological background of phenotypical variability in frontotemporal dementia , 2011, Acta Neuropathologica.

[123]  Theresa M. Harrison,et al.  Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia , 2011, Neurology.

[124]  Robert V Farese,et al.  Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription , 2011, The Journal of Biological Chemistry.

[125]  Karsten Mueller,et al.  Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia , 2011, PloS one.

[126]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[127]  Sébastien Ourselin,et al.  Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations☆ , 2010, NeuroImage.

[128]  Nick C Fox,et al.  Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[129]  J. Trojanowski,et al.  Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia , 2010, Neurology.

[130]  C. Jack,et al.  Caudate atrophy on MRI is a characteristic feature of FTLD‐FUS , 2010, European journal of neurology.

[131]  J. Trojanowski,et al.  Novel CSF biomarkers for frontotemporal lobar degenerations , 2010, Alzheimer's & Dementia.

[132]  Efstathios D. Gennatas,et al.  Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. , 2010, Brain : a journal of neurology.

[133]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[134]  J. V. van Swieten,et al.  Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration , 2009, Journal of Neurology.

[135]  Matthew L Senjem,et al.  Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. , 2009, Brain : a journal of neurology.

[136]  J. Brewer.  Fully-Automated Volumetric MRI with Normative Ranges: Translation to Clinical Practice , 2009, Behavioural neurology.

[137]  Norbert Schuff,et al.  White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI , 2009, Brain : a journal of neurology.

[138]  Nick C Fox,et al.  Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration , 2009, Neurology.

[139]  R. Petersen,et al.  Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members , 2009, Brain : a journal of neurology.

[140]  W. Jagust,et al.  Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia , 2008, Annals of neurology.

[141]  D Perani,et al.  Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. , 2008, Rejuvenation research.

[142]  J. Trojanowski,et al.  CSF biomarkers in frontotemporal lobar degeneration with known pathology , 2008, Neurology.

[143]  P. Carmeliet,et al.  Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival , 2008, The Journal of cell biology.

[144]  Maria Luisa Gorno-Tempini,et al.  Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. , 2008, Archives of neurology.

[145]  N. Bresolin,et al.  Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration , 2008, Journal of Neurology.

[146]  Michael D Greicius,et al.  Divergent Social Functioning in Behavioral Variant Frontotemporal Dementia and Alzheimer Disease: Reciprocal Networks and Neuronal Evolution , 2007, Alzheimer disease and associated disorders.

[147]  D. Yves von Cramon,et al.  Towards a nosology for frontotemporal lobar degenerations—A meta-analysis involving 267 subjects , 2007, NeuroImage.

[148]  A. Drzezga,et al.  Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study , 2007, Neurobiology of Aging.

[149]  Elisabeth Kapaki,et al.  Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia , 2006, Journal of the Neurological Sciences.

[150]  N. Schuff,et al.  Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.

[151]  A. Drzezga,et al.  Longitudinal Changes of Cerebral Glucose Metabolism in Semantic Dementia , 2006, Dementia and Geriatric Cognitive Disorders.

[152]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[153]  N. Bresolin,et al.  Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration , 2006, Neurology.

[154]  M. Weiner,et al.  Cognition and anatomy in three variants of primary progressive aphasia , 2004, Annals of neurology.

[155]  P. Scheltens,et al.  Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations. , 2003, Archives of neurology.

[156]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[157]  L S Illis,et al.  Spinal cord stimulation in multiple sclerosis: clinical results. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[158]  María Blanca Fernández-Viñéa.  CURRENT STATUS AND FUTURE PERSPECTIVES , 2018 .

[159]  B. Borroni,et al.  Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease. , 2016, Journal of Alzheimer's disease : JAD.

[160]  F. Islami,et al.  Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran , 2016, Medicine.

[161]  P. Scheltens,et al.  Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes. , 2016, Journal of Alzheimer's disease : JAD.

[162]  Simone Lista,et al.  Biomarkers in Sporadic and Familial Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[163]  H. Struyfs,et al.  Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. , 2015, Journal of Alzheimer's disease : JAD.

[164]  J. Clarimón,et al.  Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[165]  Paul M Thompson,et al.  Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[166]  J. Pariente,et al.  Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. , 2012, Journal of Alzheimer's disease : JAD.

[167]  Nick C Fox,et al.  Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. , 2012, Journal of Alzheimer's disease : JAD.

[168]  C. Nilsson,et al.  Diagnosis of frontotemporal dementia in Sweden. Data from the Swedish Dementia Registry. , 2012 .

[169]  N. Bresolin,et al.  Cerebrospinal fluid biomarkers in Progranulin mutations carriers. , 2011, Journal of Alzheimer's disease : JAD.

[170]  Nancy Reagan,et al.  Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease" , 1998 .